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Abstract
Background: Primary cardiac lymphoma is one of the rarest tumours of the heart. It belongs to the extra-nodal
non-Hodgkin’s lymphomas. The most common type of this tumour is diffuse large B cell lymphoma. Usually, right
atrium and right ventricle are involved. This tumour is fatal unless diagnosed and treated in time. In this article two
female patients who were diagnosed with primary cardiac lymphoma and treated at our clinic are described. The
first patient went to remission after the treatment, while the second patient died. The goals of this article are to
show the difficulties of diagnosing and treating this disease, the role of cardiac surgery in its treatment and to raise
awareness of this disease.
Case reports: In this article two female patients who were diagnosed with primary cardiac lymphoma and treated
at our clinic are described. The first patient went to remission after the treatment, while the second patient died.
Conclusions: Primary cardiac lymphoma is a very rare disease. At the moment the most effective treatment is
chemotherapy. Palliative surgery may be necessary to correct hemodynamics when venous blood flow to the lungs
is disturbed.
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Background
Primary cardiac lymphoma (PCL) is a rare malignant dis-
ease. A. Johri et al. state that PCL composes just 1.3 % of
all cardiac tumours [1]. L. Zhong et al. write that PCL
composes only 0.5 % of all extranodal lymphomas [2]. The
most common histological type of PCL is large B cell
lymphoma [2, 3]. PCL is fatal, unless it is diagnosed and
treated in time [4]. Patients usually die within few months
after being diagnosed with PCL [5–7]. In this article two
patients diagnosed with PCL and treated at our clinic are
presented.
Case reports
Patient 1, a 48 year old female, who had a history of pro-
gressive heart failure, dyspnoea at rest and cyanosis for
three weeks prior to hospitalization. The patient had no
complaints of fever above 38 C, night sweating or loss of
more than 10 % of body weight over a period of six or
less (B symptoms). On the day of hospitalization a trans-
thoracic echocardiography (TTE) was performed. An in-
homogeneous tumour was found in both atria. It was
almost closing the orifice of the tricuspid valve (the
diameter of the tricuspid valve orifice was 2.38 cm and
the diameter of the part of the tumour closing the orifice
was 2.25 cm) and penetrating the left ventricle via the
interventricular septum. Complete blood count (CBC)
and coagulation profile test (CPT) were within normal
limits. The patient was immunocompetent and human
immunodeficiency virus (HIV) tests were negative. Due
to a rapid and severe heart failure an open chest oper-
ation was performed, during which a biopsy of the
tumour was taken. Fast intra-operative analysis of the
specimen revealed that the tumour was malignant. Be-
cause the tumour was inoperable and the patient’s
hemodynamics was unstable, a decision was made to
perform a Fontan procedure as a palliative method in
order to stabilize the patient’s condition and to provide
time for chemotherapy. The superior vena cava (SVC)
was anastomosed to the right pulmonary artery (RPA)
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(Fig. 1). This way venous blood flow was redirected to
the lungs and obstructed right heart was bypassed. After
the surgery, the patient’s condition improved. She was
extubated on the second day after the surgery. Breathing
was spontaneous and arterial blood oxygen saturation
(SaO2) was 92 %. A detailed histological exam of the
tumour revealed that it was diffuse large B cell lymph-
oma. There were no evidence of extra-cardiac lymphoma
present, thus the final diagnosis was primary cardiac
lymphoma. When the patient recovered from the surgery,
she decided to continue her chemotherapy treatment at a
foreign oncology clinic. To the best of our knowledge, the
patient went into remission after chemotherapy.
Patient 2, a 64 year old female was diagnosed, with
acute nonspecific idiopathic pericarditis, and was re-
ferred to our clinic. She had a history of heart failure for
six months prior to hospitalisation. On the day of arrival
she presented with a decompensated heart failure. Tach-
ypnoea, hepatomegaly and ascites were present. The pa-
tient had no complaints regarding the B symptoms.
Arterial blood pressure was 100/70 mmHg. CBC and
CPT were within normal limits. HIV tests were negative,
the patient was immunocompetent. TTE revealed a se-
vere dilatation of the right atrium and right ventricle, a
large tumour in the right side of the heart and fluid ac-
cumulation in the pericardial sac. In order to specify the
diagnosis a pericardiocentesis, cardiac magnetic reson-
ance imaging (MRI) and percutaneous transvenous
biopsy (PTVB) of the tumour were performed. The peri-
cardial fluid exam showed that it was transudate with no
cells. The MRI revealed a tumour in the right atrium ap-
pendage, which was invading the right atrium and ven-
tricle and visceral pericardium. The large tumour (10 x
7.2 x 8 cm) was obstructing the right ventricle, the IVS
was pushed towards the left ventricle and slightly inter-
fering with its function (end systolic volume of the LV
was 26 ml, end diastolic volume of the LV was 53 ml
and LV EF was 52 %, cardiac index was 1. 8 l/min/m2)
(Fig. 2). PTVB of the tumour showed mild myocardial fi-
brosis. 11 days later the patient’s condition started to
worsen. An open chest biopsy of the tumour was per-
formed. A fast intra-operative histological exam of the
tumour revealed that it was malignant. Because the
tumour was inoperable, a decision to perform a Fontan
procedure was made. It was intended to stabilise the pa-
tient’s hemodynamics. After the surgery the patient’s
general condition was satisfactory. She was extubated
twelve hours later. Breathing was spontaneous and SaO2
was 90 %. Eight hours later, the patient’s condition began
to worsen. She was re-intubated. Asystole developed and
cardio-pulmonary resuscitation was initiated. All means
to save her life were ineffective. The patient passed away.
Detailed histological exam of the tumour revealed that it
was a diffuse large B cell lymphoma (immunophenotype:
non-germinal centre, CD20-positive, CD10-negative,
BCL2-positive, BCL6-positive, MUM1-positive, CD23-
negative, CD30-negative, EBER-negative) (Fig. 3).
Discussion
There are no unified criteria when this tumour can be
called primary cardiac lymphoma. L. Zaharia and P. Gill
state that PCL can be diagnosed when the tumour in-
volves the pericardial space and myocardium [8]. On the
other hand, Curtsinger et al. state that PCL can only be
diagnosed when there is cardiac lymphoma without any
other evidence of lymphoma on autopsy [9]. Both of our
patients were diagnosed with PCL’s, because histological
exams of both tumours showed they were diffuse large B
cell lymphomas. And there were no evidence of a
tumour present in any other organ of both patients.
PCL is a rare disease. It composes only 1.3 % of all car-
diac tumours and 0.5 % of all extranodal lymphomas [1, 2].
The largest review of case-reports and case-series was per-
formed by Petrich et al. It included 197 cases of PCL re-
ports from 1947 – 2009. The authors reported that this
disease is more common in the elderly age. The median
age of the patients is 63 years), although it ranged from 9 to
90 years (but only 5 patients were younger than 17 years
old) [10]. The reported male to female ratio is 2(3):1 [2, 10].
The symptoms of PCL are nonspecific. It can manifest as a
heart rhythm disturbance, episodic syncope, vena cava su-
perior syndrome, respiratory distress [2] or even as a
Fig. 1 Schema of the procedure performed for the first patient
(drawing by O. Barysaite). Black arrows indicate venous blood flow
through the right side of the heart
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restrictive cardiomyopathy [1, 2, 11]. However, the most
common symptoms are dyspnoea, constitutional com-
plaints (fever, chills, sweats and weight loss), chest pain,
heart failure and pericardial effusion [2, 10]. PCL is more
likely to involve the right heart (both atrium and ventricle
alike), but there are cases were only the left heart was in-
volved [1, 2, 10, 12–15].
Patients who are suspected of having a PCL must be
examined thoroughly. The examination must include
echocardiography, heart computed tomography or MRI
study, but the final diagnosis can be made only after a
histological evaluation of the tumour is obtained. Usually
PTVB with transesophageal echocardiographic (TEE)
control is used to obtain the specimen [14, 15]. D. Jurko-
vich et al. has successfully used a combined fluoroscopic
imaging and TEE for PTVB [16]. However, in our sec-
ond case PTVB failed to provide any clinically signifi-
cant data.
PCL treatment is combined of surgery and chemother-
apy. The literature indicates, that when treating with
chemotherapy alone 61 % of patients have a remission,
while surgery alone has no effect to the outcome [15].
However, surgery is the only method which can provide
time for chemotherapy to have a therapeutic effect, espe-
cially when hemodynamics is disturbed. If the tumour is
localized in the right ventricular outflow tract (RVOT)
and partially or fully occludes the outflow tract, the
prognosis is worse [3]. Even in the case of RVOT ob-
struction surgical treatment does not change the out-
come prognosis. As stated by Y. H. Jung et al. it is
necessary to diagnose PCL as early as possible, to use in-
tensive treatment with new chemotherapy drugs in order
to achieve better outcomes for the patients [3]. K. W.
Chen et al. and later A. Habertheuer et al. reported suc-
cessful recovery of patients after surgical removal of the
tumour and postoperative chemotherapy [4, 17].
It was impossible to remove the tumour of either pa-
tient. They underwent a surgery because of the obstructed
Fig. 2 Preoperative patient 2 Heart MRI. a 4 chambers GRE view. Hypointensive masses visible in right ventricle, right atrium and right
atrial appendage (red arrow). The tumour is obstructing the right ventricle and compressing the interventricular septum, and the left
ventricle. b 2 chambers GRE view. Hypointensive masses in the right ventricle and right atrium (red arrow). c 4 chambers view perfusion
sequence. Perfusion is seen in the masses (red arrow). d 4 chambers view. Non homogenous gadolinium enhancement is visible (red arrow).
All images were taken during diastole
Fig. 3 Patient 2 tumour histology. Diffuse myocardial infiltration with
large B cells (Hematoxylin-eosin stain, original magnification × 200)
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blood flow to the lungs. The main goal of the procedure
was to provide patients with time for chemotherapy to
have a therapeutic effect. Our first patient survived the
procedure and went to remission after chemotherapy. Our
second patient, died on the first day after surgery. It is un-
known why the outcome of both patients was different. It
is possible that the difference in outcomes is related to the
elderly age and far more developed initial heart failure of
the second patient.
Conclusions
Primary cardiac lymphoma is a very rare disease. At the
moment the most effective treatment is chemotherapy. Pal-
liative surgery may be necessary to correct hemodynamics
when venous blood flow to the lungs is disturbed.
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